Fagron NV a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, and patients worldwide.
Business Segments
The company categorizes its operations into three primary segments: Essentials, B…
Analysis
Quality compounder
Fagron NV is a quality compounder: a well-run business trading at a price that reflects what it is worth. One caution: reported profits have recently run ahead of actual cash, which we track closely.
The price is fair. You pay 18.0× its owner earnings: the cash an owner could take out each year, which is in the historically fair zone.
The trajectory is moderate and the balance sheet is sturdy. The company scores 18/20 on our value-creation score: strong value creator.
What to watch: Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.
360° rank · history
1007550250
Jan 20233
100
2023202420252026
All-time high
100
Jun 2026
All-time low
3
Jan 2023
Average rank
65
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
72
17
23
28
Price/Earnings
42
47
51
66
Price/Book
51
29
43
41
Dividend Yield
73
49
43
26
Value (overall)
73
20
26
23
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.